BrYet US, Inc.

  • Biotech or pharma, therapeutic R&D

New metastatic cancer targeting based on physics of mass transport; first CTA Q2 2025; outstanding efficacy published Nature/Science journals; platform + pipeline; well funded; $100 M+ science grants UWashington Houston Methodist MDAnderson UC Berkeley. Focused on metastasis to lung and liver of cancer of any origin.

Address

Houston
Texas
United States

Website

https://bryetpharma.com/

Contact Exhibitor


Loading
View all Partnering Companies

BIO DOUBLE HELIX SPONSORS

Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.

BIO HELIX SPONSORS